Nemolizumab Versus Dupilumab in the Treatment of Prurigo Nodularis: Systematic Literature Review and Network Meta-analysis.

Yosipovitch G, Borkowska K, Frampton J, Schaible K, Betts M, Jack K, Jabbar Lopez Z, Neupane B, Piketty C, Subramanian R, Fernández de Trocóniz JP

Open source

DOI: 10.1007/s13555-026-01827-6
Published: 2026 Aug
Container: Dermatology and therapy
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s13555-026-01827-6,
  title = {Nemolizumab Versus Dupilumab in the Treatment of Prurigo Nodularis: Systematic Literature Review and Network Meta-analysis.},
  author = {Yosipovitch G and Borkowska K and Frampton J and Schaible K and Betts M and Jack K and Jabbar Lopez Z and Neupane B and Piketty C and Subramanian R and Fernández de Trocóniz JP},
  year = {2026},
  journal = {Dermatology and therapy},
  doi = {10.1007/s13555-026-01827-6},
  url = {https://doi.org/10.1007/s13555-026-01827-6}
}

RIS

TY  - JOUR
TI  - Nemolizumab Versus Dupilumab in the Treatment of Prurigo Nodularis: Systematic Literature Review and Network Meta-analysis.
AU  - Yosipovitch G
AU  - Borkowska K
AU  - Frampton J
AU  - Schaible K
AU  - Betts M
AU  - Jack K
AU  - Jabbar Lopez Z
AU  - Neupane B
AU  - Piketty C
AU  - Subramanian R
AU  - Fernández de Trocóniz JP
PY  - 2026
JO  - Dermatology and therapy
DO  - 10.1007/s13555-026-01827-6
UR  - https://doi.org/10.1007/s13555-026-01827-6
ER  -

APA

G, Y., K, B., J, F., K, S., M, B., K, J., Z, J. L., B, N., C, P., R, S., & JP, F. D. T. (2026). Nemolizumab Versus Dupilumab in the Treatment of Prurigo Nodularis: Systematic Literature Review and Network Meta-analysis.. Dermatology and therapy. https://doi.org/10.1007/s13555-026-01827-6

Source records

pubmed · retrieved 2026-09-26T11:33:06.978Z